Metarrestin

N/A

Report date: 2024/03/09 20:00:41
NME

Base Information

Drug NameMetarrestin
Drug Alias NameML-246
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA synthesis inhibitors
TargetsRNA polymerase I
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsColorectal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsColorectal Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A